Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence X Yu

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Pharmaceutics|June 5, 2016
Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product qualityThomas F O'Connor, Lawrence X Yu, Sau L Lee
Advanced Drug Delivery Reviews|January 2, 2007
Pharmaceutical impurities: analytical, toxicological and regulatory perspectivesArup K Basak, Andre S Raw, Lawrence X Yu
AAPS Pharmsci|June 7, 2002
Evaluation of USP apparatus 3 for dissolution testing of immediate-release productsLawrence X Yu, Jin T Wang, Ajaz S Hussain
Therapeutic Delivery|June 7, 2013
Innovative approaches for demonstration of bioequivalence: the US FDA perspectiveXinyuan Zhang, Nan Zheng, Robert A Lionberger, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2012
Prediction of volume of distribution at steady state in humans: comparison of different approachesPeng Zou, Nan Zheng, Yongsheng Yang, et al.
AAPS Pharmscitech|January 9, 2013
Application of quality by design to the process development of botanical drug products: a case studyLei Zhang, Binjun Yan, Xingchu Gong, et al.
The AAPS Journal|January 6, 2011
Utility of physiologically based absorption modeling in implementing Quality by Design in drug developmentXinyuan Zhang, Robert A Lionberger, Barbara M Davit, et al.
Molecular Pharmaceutics|December 20, 2012
In vitro bioequivalence approach for a locally acting gastrointestinal drug: lanthanum carbonateYongsheng Yang, Rakhi B Shah, Lawrence X Yu, et al.
The AAPS Journal|July 4, 2013
International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differencesBarbara Davit, April C Braddy, Dale P Conner, et al.
The AAPS Journal|April 12, 2011
Dissolution testing for generic drugs: an FDA perspectiveOm Anand, Lawrence X Yu, Dale P Conner, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Pharmaceutics|June 5, 2016
Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product qualityThomas F O'Connor, Lawrence X Yu, Sau L Lee
Advanced Drug Delivery Reviews|January 2, 2007
Pharmaceutical impurities: analytical, toxicological and regulatory perspectivesArup K Basak, Andre S Raw, Lawrence X Yu
AAPS Pharmsci|June 7, 2002
Evaluation of USP apparatus 3 for dissolution testing of immediate-release productsLawrence X Yu, Jin T Wang, Ajaz S Hussain
Therapeutic Delivery|June 7, 2013
Innovative approaches for demonstration of bioequivalence: the US FDA perspectiveXinyuan Zhang, Nan Zheng, Robert A Lionberger, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 18, 2012
Prediction of volume of distribution at steady state in humans: comparison of different approachesPeng Zou, Nan Zheng, Yongsheng Yang, et al.
AAPS Pharmscitech|January 9, 2013
Application of quality by design to the process development of botanical drug products: a case studyLei Zhang, Binjun Yan, Xingchu Gong, et al.
The AAPS Journal|January 6, 2011
Utility of physiologically based absorption modeling in implementing Quality by Design in drug developmentXinyuan Zhang, Robert A Lionberger, Barbara M Davit, et al.
Molecular Pharmaceutics|December 20, 2012
In vitro bioequivalence approach for a locally acting gastrointestinal drug: lanthanum carbonateYongsheng Yang, Rakhi B Shah, Lawrence X Yu, et al.
The AAPS Journal|July 4, 2013
International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differencesBarbara Davit, April C Braddy, Dale P Conner, et al.
The AAPS Journal|April 12, 2011
Dissolution testing for generic drugs: an FDA perspectiveOm Anand, Lawrence X Yu, Dale P Conner, et al.
Pageof 8